カテゴリ： Market Monitor Global, 世界, 医療/バイオ

抗潰瘍剤&胃酸抑制剤のグローバル市場展望 2023年-2029年：10mg、20mg、30mg、100mg、その他

■ 英語タイトル：Antiulcer Agents and Acid Suppressants Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5692）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5692
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗潰瘍剤&胃酸抑制剤のグローバル市場展望 2023年-2029年：10mg、20mg、30mg、100mg、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の抗潰瘍剤&胃酸抑制剤市場規模と予測を収録しています。・世界の抗潰瘍剤&胃酸抑制剤市場：売上、2018年-2023年、2024年-2029年
・世界の抗潰瘍剤&胃酸抑制剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗潰瘍剤&胃酸抑制剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「10mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

抗潰瘍剤&胃酸抑制剤のグローバル主要企業は、Pfizer、 Sandoz、 Alcon、 Teva Pharmaceuticals、 Sun Pharmaceutical Industries、 Takeda、 Camber Pharmaceuticals、 Carlsbad Technologies、 Advagen Pharma、 Gavis Pharmaceuticals、 Generic、 Akorn、 Lannett、 Lupin Pharmaceuticals、 Methaparm、 Nostrum Laboratories、 Precision Dose、 Athenex、 AuroMedics Pharma、 Fresenius Kabi、 Astra Zeneca Pharm、 Glenmark Pharmaceuticals、 Aurobindo Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、抗潰瘍剤&胃酸抑制剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗潰瘍剤&胃酸抑制剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗潰瘍剤&胃酸抑制剤市場：タイプ別市場シェア、2022年
・10mg、20mg、30mg、100mg、その他

世界の抗潰瘍剤&胃酸抑制剤市場：用途別、2018年-2023年、2024年-2029年
世界の抗潰瘍剤&胃酸抑制剤市場：用途別市場シェア、2022年
・病院、診療所、薬局、その他

世界の抗潰瘍剤&胃酸抑制剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗潰瘍剤&胃酸抑制剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗潰瘍剤&胃酸抑制剤のグローバル売上、2018年-2023年
・主要企業における抗潰瘍剤&胃酸抑制剤のグローバル売上シェア、2022年
・主要企業における抗潰瘍剤&胃酸抑制剤のグローバル販売量、2018年-2023年
・主要企業における抗潰瘍剤&胃酸抑制剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、 Sandoz、 Alcon、 Teva Pharmaceuticals、 Sun Pharmaceutical Industries、 Takeda、 Camber Pharmaceuticals、 Carlsbad Technologies、 Advagen Pharma、 Gavis Pharmaceuticals、 Generic、 Akorn、 Lannett、 Lupin Pharmaceuticals、 Methaparm、 Nostrum Laboratories、 Precision Dose、 Athenex、 AuroMedics Pharma、 Fresenius Kabi、 Astra Zeneca Pharm、 Glenmark Pharmaceuticals、 Aurobindo Pharma

*************************************************************

・調査・分析レポートの概要
抗潰瘍剤&胃酸抑制剤市場の定義
市場セグメント
世界の抗潰瘍剤&胃酸抑制剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗潰瘍剤&胃酸抑制剤市場規模
世界の抗潰瘍剤&胃酸抑制剤市場規模：2022年 VS 2029年
世界の抗潰瘍剤&胃酸抑制剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗潰瘍剤&胃酸抑制剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗潰瘍剤&胃酸抑制剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：10mg、20mg、30mg、100mg、その他
抗潰瘍剤&胃酸抑制剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、薬局、その他
抗潰瘍剤&胃酸抑制剤の用途別グローバル売上・予測

・地域別市場分析
地域別抗潰瘍剤&胃酸抑制剤市場規模 2022年と2029年
地域別抗潰瘍剤&胃酸抑制剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Sandoz、 Alcon、 Teva Pharmaceuticals、 Sun Pharmaceutical Industries、 Takeda、 Camber Pharmaceuticals、 Carlsbad Technologies、 Advagen Pharma、 Gavis Pharmaceuticals、 Generic、 Akorn、 Lannett、 Lupin Pharmaceuticals、 Methaparm、 Nostrum Laboratories、 Precision Dose、 Athenex、 AuroMedics Pharma、 Fresenius Kabi、 Astra Zeneca Pharm、 Glenmark Pharmaceuticals、 Aurobindo Pharma
...

This report aims to provide a comprehensive presentation of the global market for Antiulcer Agents and Acid Suppressants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiulcer Agents and Acid Suppressants. This report contains market size and forecasts of Antiulcer Agents and Acid Suppressants in global, including the following market information:
Global Antiulcer Agents and Acid Suppressants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Antiulcer Agents and Acid Suppressants market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
10 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antiulcer Agents and Acid Suppressants include Pfizer, Sandoz, Alcon, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Takeda, Camber Pharmaceuticals, Carlsbad Technologies and Advagen Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiulcer Agents and Acid Suppressants companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiulcer Agents and Acid Suppressants Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Antiulcer Agents and Acid Suppressants Market Segment Percentages, by Type, 2022 (%)
10 mg
20 mg
30 mg
100 mg
Others
Global Antiulcer Agents and Acid Suppressants Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Antiulcer Agents and Acid Suppressants Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Pharmacy
Others
Global Antiulcer Agents and Acid Suppressants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Antiulcer Agents and Acid Suppressants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiulcer Agents and Acid Suppressants revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antiulcer Agents and Acid Suppressants revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sandoz
Alcon
Teva Pharmaceuticals
Sun Pharmaceutical Industries
Takeda
Camber Pharmaceuticals
Carlsbad Technologies
Advagen Pharma
Gavis Pharmaceuticals
Generic
Akorn
Lannett
Lupin Pharmaceuticals
Methaparm
Nostrum Laboratories
Precision Dose
Athenex
AuroMedics Pharma
Fresenius Kabi
Astra Zeneca Pharm
Glenmark Pharmaceuticals
Aurobindo Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiulcer Agents and Acid Suppressants, market overview.
Chapter 2: Global Antiulcer Agents and Acid Suppressants market size in revenue.
Chapter 3: Detailed analysis of Antiulcer Agents and Acid Suppressants company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiulcer Agents and Acid Suppressants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Antiulcer Agents and Acid Suppressants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiulcer Agents and Acid Suppressants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiulcer Agents and Acid Suppressants Overall Market Size
2.1 Global Antiulcer Agents and Acid Suppressants Market Size: 2022 VS 2029
2.2 Global Antiulcer Agents and Acid Suppressants Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiulcer Agents and Acid Suppressants Players in Global Market
3.2 Top Global Antiulcer Agents and Acid Suppressants Companies Ranked by Revenue
3.3 Global Antiulcer Agents and Acid Suppressants Revenue by Companies
3.4 Top 3 and Top 5 Antiulcer Agents and Acid Suppressants Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiulcer Agents and Acid Suppressants Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiulcer Agents and Acid Suppressants Players in Global Market
3.6.1 List of Global Tier 1 Antiulcer Agents and Acid Suppressants Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiulcer Agents and Acid Suppressants Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Antiulcer Agents and Acid Suppressants Market Size Markets, 2022 & 2029
4.1.2 10 mg
4.1.3 20 mg
4.1.4 30 mg
4.1.5 100 mg
4.1.6 Others
4.2 By Type – Global Antiulcer Agents and Acid Suppressants Revenue & Forecasts
4.2.1 By Type – Global Antiulcer Agents and Acid Suppressants Revenue, 2018-2023
4.2.2 By Type – Global Antiulcer Agents and Acid Suppressants Revenue, 2024-2029
4.2.3 By Type – Global Antiulcer Agents and Acid Suppressants Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antiulcer Agents and Acid Suppressants Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Pharmacy
5.1.5 Others
5.2 By Application – Global Antiulcer Agents and Acid Suppressants Revenue & Forecasts
5.2.1 By Application – Global Antiulcer Agents and Acid Suppressants Revenue, 2018-2023
5.2.2 By Application – Global Antiulcer Agents and Acid Suppressants Revenue, 2024-2029
5.2.3 By Application – Global Antiulcer Agents and Acid Suppressants Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Antiulcer Agents and Acid Suppressants Market Size, 2022 & 2029
6.2 By Region – Global Antiulcer Agents and Acid Suppressants Revenue & Forecasts
6.2.1 By Region – Global Antiulcer Agents and Acid Suppressants Revenue, 2018-2023
6.2.2 By Region – Global Antiulcer Agents and Acid Suppressants Revenue, 2024-2029
6.2.3 By Region – Global Antiulcer Agents and Acid Suppressants Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Antiulcer Agents and Acid Suppressants Revenue, 2018-2029
6.3.2 US Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.3.3 Canada Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.3.4 Mexico Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Antiulcer Agents and Acid Suppressants Revenue, 2018-2029
6.4.2 Germany Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4.3 France Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4.4 U.K. Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4.5 Italy Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4.6 Russia Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4.7 Nordic Countries Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.4.8 Benelux Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Antiulcer Agents and Acid Suppressants Revenue, 2018-2029
6.5.2 China Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.5.3 Japan Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.5.4 South Korea Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.5.5 Southeast Asia Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.5.6 India Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Antiulcer Agents and Acid Suppressants Revenue, 2018-2029
6.6.2 Brazil Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.6.3 Argentina Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Antiulcer Agents and Acid Suppressants Revenue, 2018-2029
6.7.2 Turkey Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.7.3 Israel Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.7.4 Saudi Arabia Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
6.7.5 UAE Antiulcer Agents and Acid Suppressants Market Size, 2018-2029
7 Antiulcer Agents and Acid Suppressants Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antiulcer Agents and Acid Suppressants Major Product Offerings
7.1.4 Pfizer Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Sandoz
7.2.1 Sandoz Company Summary
7.2.2 Sandoz Business Overview
7.2.3 Sandoz Antiulcer Agents and Acid Suppressants Major Product Offerings
7.2.4 Sandoz Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.2.5 Sandoz Key News & Latest Developments
7.3 Alcon
7.3.1 Alcon Company Summary
7.3.2 Alcon Business Overview
7.3.3 Alcon Antiulcer Agents and Acid Suppressants Major Product Offerings
7.3.4 Alcon Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.3.5 Alcon Key News & Latest Developments
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Company Summary
7.4.2 Teva Pharmaceuticals Business Overview
7.4.3 Teva Pharmaceuticals Antiulcer Agents and Acid Suppressants Major Product Offerings
7.4.4 Teva Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.4.5 Teva Pharmaceuticals Key News & Latest Developments
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Company Summary
7.5.2 Sun Pharmaceutical Industries Business Overview
7.5.3 Sun Pharmaceutical Industries Antiulcer Agents and Acid Suppressants Major Product Offerings
7.5.4 Sun Pharmaceutical Industries Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.5.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.6 Takeda
7.6.1 Takeda Company Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Antiulcer Agents and Acid Suppressants Major Product Offerings
7.6.4 Takeda Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.6.5 Takeda Key News & Latest Developments
7.7 Camber Pharmaceuticals
7.7.1 Camber Pharmaceuticals Company Summary
7.7.2 Camber Pharmaceuticals Business Overview
7.7.3 Camber Pharmaceuticals Antiulcer Agents and Acid Suppressants Major Product Offerings
7.7.4 Camber Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.7.5 Camber Pharmaceuticals Key News & Latest Developments
7.8 Carlsbad Technologies
7.8.1 Carlsbad Technologies Company Summary
7.8.2 Carlsbad Technologies Business Overview
7.8.3 Carlsbad Technologies Antiulcer Agents and Acid Suppressants Major Product Offerings
7.8.4 Carlsbad Technologies Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.8.5 Carlsbad Technologies Key News & Latest Developments
7.9 Advagen Pharma
7.9.1 Advagen Pharma Company Summary
7.9.2 Advagen Pharma Business Overview
7.9.3 Advagen Pharma Antiulcer Agents and Acid Suppressants Major Product Offerings
7.9.4 Advagen Pharma Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.9.5 Advagen Pharma Key News & Latest Developments
7.10 Gavis Pharmaceuticals
7.10.1 Gavis Pharmaceuticals Company Summary
7.10.2 Gavis Pharmaceuticals Business Overview
7.10.3 Gavis Pharmaceuticals Antiulcer Agents and Acid Suppressants Major Product Offerings
7.10.4 Gavis Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.10.5 Gavis Pharmaceuticals Key News & Latest Developments
7.11 Generic
7.11.1 Generic Company Summary
7.11.2 Generic Business Overview
7.11.3 Generic Antiulcer Agents and Acid Suppressants Major Product Offerings
7.11.4 Generic Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.11.5 Generic Key News & Latest Developments
7.12 Akorn
7.12.1 Akorn Company Summary
7.12.2 Akorn Business Overview
7.12.3 Akorn Antiulcer Agents and Acid Suppressants Major Product Offerings
7.12.4 Akorn Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.12.5 Akorn Key News & Latest Developments
7.13 Lannett
7.13.1 Lannett Company Summary
7.13.2 Lannett Business Overview
7.13.3 Lannett Antiulcer Agents and Acid Suppressants Major Product Offerings
7.13.4 Lannett Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.13.5 Lannett Key News & Latest Developments
7.14 Lupin Pharmaceuticals
7.14.1 Lupin Pharmaceuticals Company Summary
7.14.2 Lupin Pharmaceuticals Business Overview
7.14.3 Lupin Pharmaceuticals Antiulcer Agents and Acid Suppressants Major Product Offerings
7.14.4 Lupin Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.14.5 Lupin Pharmaceuticals Key News & Latest Developments
7.15 Methaparm
7.15.1 Methaparm Company Summary
7.15.2 Methaparm Business Overview
7.15.3 Methaparm Antiulcer Agents and Acid Suppressants Major Product Offerings
7.15.4 Methaparm Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.15.5 Methaparm Key News & Latest Developments
7.16 Nostrum Laboratories
7.16.1 Nostrum Laboratories Company Summary
7.16.2 Nostrum Laboratories Business Overview
7.16.3 Nostrum Laboratories Antiulcer Agents and Acid Suppressants Major Product Offerings
7.16.4 Nostrum Laboratories Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.16.5 Nostrum Laboratories Key News & Latest Developments
7.17 Precision Dose
7.17.1 Precision Dose Company Summary
7.17.2 Precision Dose Business Overview
7.17.3 Precision Dose Antiulcer Agents and Acid Suppressants Major Product Offerings
7.17.4 Precision Dose Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.17.5 Precision Dose Key News & Latest Developments
7.18 Athenex
7.18.1 Athenex Company Summary
7.18.2 Athenex Business Overview
7.18.3 Athenex Antiulcer Agents and Acid Suppressants Major Product Offerings
7.18.4 Athenex Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.18.5 Athenex Key News & Latest Developments
7.19 AuroMedics Pharma
7.19.1 AuroMedics Pharma Company Summary
7.19.2 AuroMedics Pharma Business Overview
7.19.3 AuroMedics Pharma Antiulcer Agents and Acid Suppressants Major Product Offerings
7.19.4 AuroMedics Pharma Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.19.5 AuroMedics Pharma Key News & Latest Developments
7.20 Fresenius Kabi
7.20.1 Fresenius Kabi Company Summary
7.20.2 Fresenius Kabi Business Overview
7.20.3 Fresenius Kabi Antiulcer Agents and Acid Suppressants Major Product Offerings
7.20.4 Fresenius Kabi Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.20.5 Fresenius Kabi Key News & Latest Developments
7.21 Astra Zeneca Pharm
7.21.1 Astra Zeneca Pharm Company Summary
7.21.2 Astra Zeneca Pharm Business Overview
7.21.3 Astra Zeneca Pharm Antiulcer Agents and Acid Suppressants Major Product Offerings
7.21.4 Astra Zeneca Pharm Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.21.5 Astra Zeneca Pharm Key News & Latest Developments
7.22 Glenmark Pharmaceuticals
7.22.1 Glenmark Pharmaceuticals Company Summary
7.22.2 Glenmark Pharmaceuticals Business Overview
7.22.3 Glenmark Pharmaceuticals Antiulcer Agents and Acid Suppressants Major Product Offerings
7.22.4 Glenmark Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.22.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.23 Aurobindo Pharma
7.23.1 Aurobindo Pharma Company Summary
7.23.2 Aurobindo Pharma Business Overview
7.23.3 Aurobindo Pharma Antiulcer Agents and Acid Suppressants Major Product Offerings
7.23.4 Aurobindo Pharma Antiulcer Agents and Acid Suppressants Revenue in Global Market (2018-2023)
7.23.5 Aurobindo Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アミトリプチリンのグローバル市場展望 2023年-2029年：10mg、20mg、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5692 )"抗潰瘍剤&胃酸抑制剤のグローバル市場展望 2023年-2029年：10mg、20mg、30mg、100mg、その他" (英文：Antiulcer Agents and Acid Suppressants Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。